21685540|south|C1710133|start=32|end=37|CONC
21685540|context|C0542559|start=46|end=53|CONC
21685540|need|C0027552^C0686904|start=66|end=70|CONC
21685540|dose|C0869039^C0178602|start=74|end=78|CONC
21685540|increase|C0442805|start=79|end=87|CONC
21685540|concurrent|C0205420|start=103|end=113|CONC
21685540|therapy|C0039798^C0087111|start=125|end=132|PROC^CONC
21685540|background|C1706907|start=134|end=144|CONC
21685540|increasing|C0442808|start=146|end=156|CONC
21685540|dose|C0869039^C0178602|start=173|end=177|CONC
21685540|daily|C0332173|start=200|end=205|CONC
21685540|concomitant|C0521115|start=230|end=241|CONC
21685540|induction|C0857127^C0205263|start=263|end=272|PROC^CONC
21685540|cytochrome p450|C1149063|start=276|end=291|PHYS
21685540|may|C3812381|start=303|end=306|CONC
21685540|plasma|C1609077^C0032105^C1546740|start=318|end=324|ANAT^CONC
21685540|concentrations|C0086045|start=325|end=339|PHYS
21685540|methods|C0025664^C0449851^C0025663|start=341|end=348|CONC
21685540|south africa|C0037712|start=377|end=389|GEOG
21685540|based|C1705938^C1527178|start=408|end=413|CONC
21685540|antiretroviral therapy|C1963724|start=414|end=436|PROC
21685540|concomitant|C0521115|start=442|end=453|CONC
21685540|tuberculosis|C0041296|start=454|end=466|DISO
21685540|increased|C0442805^C0205217|start=495|end=504|CONC
21685540|standard|C1548173^C1442989^C2828392^C3272550|start=517|end=525|CONC
21685540|dose|C0869039^C0178602|start=535|end=539|CONC
21685540|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=554|end=563|PROC^CONC
21685540|therapy|C0039798^C0087111|start=574|end=581|PROC^CONC
21685540|mid|C0444598|start=620|end=623|CONC
21685540|interval|C1552654^C1552713^C1272706|start=631|end=639|CONC
21685540|concentrations|C0086045|start=644|end=658|PHYS
21685540|individual|C3245468^C1550471|start=685|end=695|CONC
21685540|4 weeks|C1442465|start=703|end=710|CONC
21685540|concomitant|C0521115|start=714|end=725|CONC
21685540|therapy|C0039798^C0087111|start=738|end=745|PROC^CONC
21685540|4 weeks|C1442465|start=754|end=761|CONC
21685540|therapy|C0039798^C0087111|start=771|end=778|PROC^CONC
21685540|completion|C1554962^C0205197|start=779|end=789|CONC
21685540|mid|C0444598|start=791|end=794|CONC
21685540|interval|C1552654^C1552713^C1272706|start=802|end=810|CONC
21685540|concentrations|C0086045|start=815|end=829|PHYS
21685540|compared|C1707455|start=835|end=843|ACTI
21685540|signed|C1561610^C1519316|start=882|end=888|CONC
21685540|rank|C0699794^C2827557^C1420805|start=889|end=893|GENE^CONC
21685540|test|C0022885^C0039593^C1704435^C2826273^C0392366|start=894|end=898|PROC^CONC
21685540|paired|C1709450|start=909|end=915|CONC
21685540|collected|C1516698^C1516695|start=929|end=938|CONC
21685540|women|C1552469|start=983|end=988|OBJC^ORGA
21685540|median|C0876920^C2347635^C2939193^C0549183^C2348144|start=993|end=999|CONC
21685540|weight|C1705104^C0043100^C1305866^C0944911^C0005910|start=1000|end=1006|PROC^PHYS^CONC
21685540|antiretroviral therapy|C1963724|start=1033|end=1055|PROC
21685540|start|C0439659^C1552850|start=1056|end=1061|CONC
21685540|median|C0876920^C2347635^C2939193^C0549183^C2348144|start=1063|end=1069|CONC
21685540|cd4|C3541261^C1332714|start=1070|end=1073|PROC^GENE
21685540|t-cell|C0039194|start=1077|end=1083|ANAT
21685540|count|C1705566^C0750480|start=1084|end=1089|ACTI^CONC
21685540|cells|C3282337^C0007634|start=1098|end=1103|ANAT
21685540|median|C0876920^C2347635^C2939193^C0549183^C2348144|start=1124|end=1130|CONC
21685540|viral load|C1261478|start=1131|end=1141|PROC
21685540|log|C2986775^C1708728|start=1150|end=1153|ACTI^CONC
21685540|total|C0439810|start=1171|end=1176|CONC
21685540|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=1227|end=1236|PROC^CONC
21685540|concentrations|C0086045|start=1267|end=1281|PHYS
21685540|group|C1552516^C1561557^C1705428^C0441833|start=1296|end=1301|ORGA^CONC
21685540|significant|C0750502^C1546944^C0237881|start=1410|end=1421|CONC
21685540|difference|C1705242^C1705241|start=1422|end=1432|CONC
21685540|concentrations|C0086045|start=1440|end=1454|PHYS
21685540|group|C1552516^C1561557^C1705428^C0441833|start=1539|end=1544|ORGA^CONC
21685540|increase|C0442805|start=1559|end=1567|CONC
21685540|adverse effects|C0879626^C0001688|start=1582|end=1597|DISO^CONC
21685540|group|C1552516^C1561557^C1705428^C0441833|start=1608|end=1613|ORGA^CONC
21685540|proportion|C1709707|start=1619|end=1629|CONC
21685540|suppressed|C1260953|start=1647|end=1657|CONC
21685540|weeks|C0439230|start=1676|end=1681|CONC
21685540|similar|C2348205|start=1686|end=1693|CONC
21685540|groups|C1552839^C0441833|start=1702|end=1708|CONC
21685540|conclusions|C1707478|start=1710|end=1721|CONC
21685540|concentrations|C0086045|start=1727|end=1741|PHYS
21685540|increased|C0442805^C0205217|start=1761|end=1770|CONC
21685540|group|C1552516^C1561557^C1705428^C0441833|start=1789|end=1794|ORGA^CONC
21685540|significant|C0750502^C1546944^C0237881|start=1816|end=1827|CONC
21685540|decrease|C0392756^C0547047|start=1828|end=1836|CONC
21685540|concentrations|C0086045|start=1844|end=1858|PHYS
21685540|group|C1552516^C1561557^C1705428^C0441833|start=1885|end=1890|ORGA^CONC
21685540|dose escalation|C3816728^C2983683|start=1892|end=1907|PROC^CONC
21685540|not required|C1611645^C1546856|start=1935|end=1947|CONC
21685540|concomitant|C0521115|start=1955|end=1966|CONC
21685540|therapy|C0039798^C0087111|start=1970|end=1977|PROC^CONC
21685540|south africa|C0037712|start=1981|end=1993|GEOG
